| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.5 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |